Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Relapser Genotype 2 Hepatitis C Infected Patients
Clinical trial NCT01466192 · COMPLETED
Trial details
- NCT number
- NCT01466192
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2013-08-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.